IL-6 promotes the abnormal proliferation of cancer cells through the activation of the IL-6/STAT3 pathway, and the proliferation genes of cancer cells, such as Ras, Src, and cyclin D1, are the direct targets of STAT3 (82). This evidence concerns the gene STAT3 and cancer.